Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

This study has been terminated.
Information provided by:
Sidney Kimmel Comprehensive Cancer Center Identifier:
First received: June 8, 2007
Last updated: December 16, 2008
Last verified: December 2008
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2010
  Estimated Primary Completion Date: No date given